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Extensive use of stent-grafts in the iliac arteries is an increasingly common endovascular alternative to an aortobifemoral
bypass procedure. The treatment of diffuse bilateral disease is frequently performed by using the technique of paired
stent-grafts in the proximal common iliac arteries to effectively re-create the aortic-bifurcation. We present three patients
treated with this technique who returned with recurrent occlusive disease. During subsequent treatment, the stent-grafts
were noted to be in different positions from where they were initially deployed. A discussion of the possible explanations
for the shifting positions follows. ( J Vasc Surg 2006;43:383-7.)Extensive use of stents or stent-grafts in the iliac arteries
is an increasingly common endovascular alternative to an
aortobifemoral bypass procedure.1-7 In our early experi-
ence, we frequently performed this procedure using the
technique of paired stent-grafts in the proximal common
iliac arteries to effectively re-create the aortic bifurcation.
We present three patients treated with this technique who
returned with recurrent occlusive disease. During subse-
quent treatment, the stent-grafts were noted to be in
different positions from where they were initially deployed.
A discussion of the possible explanations for the shifting
positions follows.
CASE REPORTS
Case 1. G. H. is a 52-year-old woman, status post a right
femoropopliteal bypass graft in the distant past, who presented
with bilateral ischemic rest pain. She had a number of comorbidi-
ties and continued to smoke 1 to 2 packs per day. Her clinical exam
was remarkable for diminished bilateral femoral pulses and an
absence of distal pedal pulses. She underwent a preoperative du-
plex evaluation, and arterial ankle-brachial-indices (ABIs) revealed
evidence consistent with bilateral iliac artery stenoses. Her femo-
ropopliteal bypass was patent.
The patient subsequently underwent a diagnostic and inter-
ventional radiologic procedure at which she was found to have
diffuse, long-segment atherosclerotic disease affecting the right
common and external iliac arteries and more focal left common
and external iliac lesions. These were treated via bilateral retro-
grade percutaneous femoral approaches by using a 0.035-inch
system. Specifically, she underwent placement of a 7-  70-mm
right Wallgraft (Boston Scientific, Natick, Mass) and a 7- 
30-mm left Wallgraft stent-graft that were angioplastied with a
7-mm balloon. She also required an additional 8-  60-mm
left-sided external iliac stent (Symphony, NMT Medical, Inc,
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gradient across either iliac system.
Two years later during a diagnostic mesenteric angiogram for
chronic abdominal pain and supportive duplex findings, complete
occlusion was noted in her right common iliac artery. The appear-
ance of the bilateral common iliac stents had changed. Although
they had been in purposeful apposition after the first procedure,
when compared with these initial films, the subsequent angiograms
demonstrated a separation of the proximal aspects of the stent-
grafts. This occlusion was successfully treated with a combination
of thrombolysis and repeat bilateral common iliac artery stent
placement using Express stents (Boston Scientific).
Case 2. E. R. is a 67-year-old woman who developed pro-
gressive and severe bilateral lower limb ischemia with associated
rest pain. She is dialysis dependent with a significant history of
cardiac disease and an associated low ejection fraction. She is a
persistent tobacco user despite a history of treated non-small-cell
lung cancer.
ABIs were 0.2 on the right and 0.4 on the left, with toe
pressures of 36 and 30, respectively. With her significant comor-
bidities, she underwent bilateral common iliac and external iliac
artery stenting and angioplasty. On the left, two 8-  70-mm
Wallgrafts were used in an overlapping fashion to cover the iliac
system and the hypogastric from the bifurcation to the distal
external iliac artery. These grafts were then angioplastied with a
7-mm balloon. The process was repeated on the right side with
three Wallgrafts (8  70 mm, 7  50 mm, and 7  30 mm)
Completion angiograms and pressure gradients demonstrated
technical success.
Two years later, she returned with dialysis-aggravated rest pain
in both legs. Duplex scanning and subsequent angiography dem-
onstrated recurrent stenoses of the left and right common iliac
artery origins with an additional stenosis in the left external iliac
artery. Interestingly, this restenosis corresponded to an area of
separation and apparent migration or shortening of her common
iliac stent-grafts.
These stenoses were successfully treated with repeat stenting
(Luminex, Bard Peripheral Vascular, Tempe, Ariz) and angio-
plasty.
Case 3. M. F. is a 62-year-old woman with 25-foot bilateral
lower-extremity claudication limiting her daily activities. Her med-
ical history includes hypothyroidism, diabetes mellitus, coronary
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continues to smoke two packs per day. ABIs were 0.47 on the right
side and 0.88 on the left. Despite conservative management, her
symptoms continued to progress, prompting a diagnostic angio-
gram that demonstrated diffuse, bilateral common and external
iliac artery disease extending to her femoral arteries, with bilateral
hypogastric artery occlusions.
She subsequently underwent bilateral femoral endarterecto-
mies with patch angioplasties and iliac stent placement along the
entire iliac system. On the left, two Wallgrafts (9  70 mm and
8  70 mm) were used with a 7-mm balloon angioplasty. On the
right, three Wallgrafts (9 70 mm, 9 50 mm, and 8 50 mm)
were used with a 7-mm balloon angioplasty. The paired common
iliac Wallgrafts were deployed simultaneously to re-create the
aortic bifurcation. There was an excellent technical result, with no
pressure gradients or radiologic evidence of residual stenosis.
She returned 5 weeks later, however, with an ischemic right
leg requiring urgent intervention. She was found to have an
occluded right common and external iliac system, likely secondary
to a persistent outflow stenosis in her distal right external iliac
artery. Additionally, there was radiographic evidence of distal
migration or foreshortening of the proximal Wallgrafts. This was
successfully treated with a thrombectomy, repeat stent placement
(Express), and angioplasty.
DISCUSSION
From January 2000 through January 2003, 160 iliac
stents and 40 iliac stent-grafts were placed in 122 patients at
our institution for the management of diffuse aortoiliac
occlusive disease. During our initial experience with these
endovascular techniques, four patients were treated with
bilateral common iliac artery stent-grafts. Early on, we
utilized stent-grafts in situations that were concerning for
an increased possibility of atheroembolism or vessel rup-
ture. The Wallgraft was the only stent-graft used in these
bilateral procedures during this time period. An additional
16 patients were treated with various makes of bilateral
common iliac artery stents. Currently, we preferentially use
stents in lieu of stent-grafts for this procedure, unless we
have a high suspicion for periprocedural atheroembolism or
rupture.
The use of endovascular stents and stent-grafts in the
common iliac arteries has risen dramatically with the grow-
ing evidence supporting its technical success, primary pa-
tency, and durability.8,9 With the use of iliac stent-grafts,
our group demonstrated a significant improvement in the
primary (70%) and assisted primary patency (88%) of iliac
lesions in patients with complicated TransAtlantic Inter-
Society Consensus (TASC) C and D lesions as measured by
Kaplan-Meier analysis at 12 months.10 Although the exact
mechanism by which endovascular therapy fails is un-
known, it appears that most failures are typically associated
with the development of in-stent intimal hyperplasia or the
redevelopment of atherosclerotic disease that leads to the
formation of an in-stent stenosis or thrombosis.11
The three patients described in our case series had
bilateral common iliac stent-grafts (Wallgraft) placed for
the initial management of their aortoiliac occlusive disease.In specific clinical situations involving bilateral proximal
common iliac lesions, our institution typically uses the
technique of paired stents or stent-grafts to effectively
recreate the aortic bifurcation and therefore protect the
origin of each common iliac artery from the potential
encroachment or obstruction by the contralateral side dur-
ing stent-graft placement and angioplasty.12 It also ensures
that the over-hanging stent-graft will not impede any future
attempts to obtain aortic access from the contralateral side.
Furthermore, to minimize the formation of proximal
end-stent intimal hyperplasia as a possible source of late
failure, the proximal margin of the stent-grafts is deployed
approximately 5 mm proximal to the origin of the common
iliac vessels. Ideally, the proximal orifice of each stent-graft
will abut one another. Because the stent-grafts are initially
in contact with one another at the time of deployment, any
separation on subsequent imaging can be visualized with-
out difficulty.
These three patients were all noted to have recurrent
Fig 1. Initial and follow-up angiograms of case-series patients
demonstrate the altered apposition (crossed arrows) of the proxi-
mal grafts (facing arrows in initial placement angiograms).disease that afforded the opportunity for repeat angio-
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at the time of the initial stent-graft placements in these
three patients demonstrated the proximal apposition of the
bilateralWallgrafts. Subsequent imaging at the time of their
complication then demonstrated the unmistakable separa-
tion of the Wallgrafts. The separation measured from the
proximal medial portion of each stent to the other stent was
4mm, 2.5mm, and 1mm for Cases 1, 2 and 3, respectively.
Although a change has clearly occurred in the positions
of the Wallgrafts, the etiology of the change and its relation
to the ensuing stenosis or obstruction is not certain. Owing
to magnification differences and the effects of radiographic
parallax, the Wallgraft diameters and lengths could not be
accurately determined from the angiogram films. Because
of the retrospective nature of this review, we did not have
computed tomography or intravascular ultrasound data to
provide additional measurements of the stent-grafts or
arteries. It is uncertain, therefore, if the separation occurred
because of migration along the common iliac vessel or
secondary to the progressive expansion and resultant fore-
shortening of the Wallgraft.
TheWallgraft is a shape-memory alloy (Mediloy) based
stent-graft with a polyester, externally mounted graft ma-
terial. The Wallgraft is well known to demonstrate a signif-
icant amount of foreshortening with its deployment.13 The
closed-cell geometry of the stent design closely links the
length of the stent-graft to its deployed diameter. For
example, a 9-mm  35-mm Wallgraft has a 35-mm length
when it is at its nominal 9-mm diameter. If the stent only
expands to 8 mm, its actual length is 53 mm. When loaded
on the delivery device, it measures60 mm in length. The
reason for the significant length variation can be seen in Fig
2. The Wallgraft’s closed-cell diamond configuration de-
sign is significantly different from more recent stent geom-
etries that use a Z-shaped, open-cell configuration. As these
stents expand, the angle z and concurrent distance XY
change much less than distance AB in the closed-cell con-
figuration, thereby accounting for the significantly lower
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Fig 2. A precise, computer-aided-drawing comparison of the
changing geometry of a closed-cell designed Wallstent and an
alternative open-cell designed stent as the stents progress from
their compressed configuration on the delivery catheter to their
deployed configuration within the lumen of the vessel.amount of foreshortening seen with these devices.It is quite possible that after deployment, the chronic
outward radial force of the shape-memory alloy-based
Wallgraft resulted in the progressive expansion and dilata-
tion of the vessel wall and thrombus. This process has been
recently shown to occur in internal carotid arteries sub-
jected to carotid stenting.14 The gradual expansion is sim-
ilar to the lengthening experienced by structural materials
exposed to chronic stresses—an engineering term referred
to as creep. Thus, as the vessel wall gradually dilates, the
Wallgraft would continue to expand towards its nominal
diameter. The resultant shortening of the stent-graft’s
overall length could then account for the proximal separa-
tion of the Wallgrafts that is seen on the follow-up angio-
grams.
We have seen similar problems with Wallgrafts that are
placed in the external iliac artery adjacent to a common
femoral artery patch angioplasty. Reoperative examinations
and intraoperative angiographic imaging have demon-
strated an increased distance between the proximal end of
the patch and the distal end of the Wallgraft. Because this
separation occurs in a retrograde direction from the patch,
it is presumed that this must be due to gradual foreshort-
ening of the stent-graft.
It is also possible, however, that the separation could be
accounted for by the slowmigration of theWallgrafts along
the lumen of the vessel. The aortic bifurcation is subject to
significant hemodynamic forces. As a unit mass of blood
encounters the flow divider of the aortic bifurcation, it
undergoes a rapid change in its direction and volume as
the flow is split between the two iliac vessels. This results
in a nozzle-type effect with significant shear stresses, veloc-
ity changes, and downstream forces that act on the stent-
graft.
In addition to the outward radial forces produced by a
Fig 3. Shear stress contour plot for a stented right iliac vs un-
stented left iliac for steady (nonphysiologic) flow.graft, there are three forces to consider: the reaction force
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to blood flow acting on the exposed proximal cross section
of the graft, and the shear force of the blood flow on the
graft wall. As the graft redirects the distal flow, the graft will
experience reactionary forces that tend to displace the graft
in a distal direction. The stent-graft with a covered surface
is subject to greater exposure to these forces than an
uncovered stent.
The pulsatile nature of blood flow results in continuous
changes in these forces throughout the cardiac cycle. The
shear force experienced by the graft is analogous to a
frictional force whose magnitude and direction are depen-
dent on the exposed area of the graft and the rate of blood
flow through the graft. The shear stress acts on the graft
walls in the direction of the flowing blood. Fig 3 shows a
representative shear stress (shear force per unit area) con-
tour plot created utilizing computational fluid hemody-
namics (FLUENT, Lebanon, NH) in a patient with a right
iliac artery stent-graft. For the purposes of this model, the
flow conditions were simulated at steady flow with a uni-
form inlet velocity of 0.25 m/s and are not intended to
simulate physiologic flow. Furthermore, the ectatic nature
of the nonstented side tends to exaggerate the flow differ-
ences between the two sides. Nonetheless, the contour plot
highlights the significant shear stresses experienced by the
stented iliac vessel compared with the native vessel. If the
sum of the forces acting on the graft exceeds the frictional
force generated by the chronic outward radial force of the
stent-graft on the arterial wall, the graft will migrate distally
until the forces re-equilibrate.
Owing to the proprietary nature of most endovascular
products, it is difficult to obtain an appropriate, standard-
ized comparison of the mechanical properties of one prod-
uct compared with another; however, bench top testing
performed by Duda et al15 produced some informative data
(Table). In a standardized comparison of the chronic out-
ward radial force of several shape-memory alloy based
stents, the Wallstent (uncovered variant of the Wallgraft)
had the lowest of the recorded values. Furthermore, the
polyester graft material used on the Wallgraft is mounted
on the outside of the stents. This may inhibit the in-growth
and incorporation of the Wallgraft into the vessel lumen.
This reduces its coefficient of friction andmaymake it more
susceptible to the significant forces at the aortic bifurcation.
This in turn, may enhance its susceptibility to distal migra-
Stent properties15
Stent
description
Stent
composition
Stent
length (cm)
Sten
weigh
Memotherm NiTi 4.00 0.2
Smart NiTi 4.05 0.2
Symphony NiTi 4.40 0.1
Wallstent* Mediloy 4.10 0.1
NiTi, Nitinol.
*Note the Wallstent’s lowest chronic outward force.tion.Furthermore, the propensity for distal migration may
be particularly pronounced if a stent or stent-graft is rela-
tively undersized for the treated vessel. We typically over-
size our stent and stent-graft selection by 10% to optimize
the sizing within the vessel wall.
CONCLUSION
The changes witnessed in these Wallgrafts are probably
the result of a combination of foreshortening and distal
migration. At this point, the relationship between these
stent-graft changes and the subsequent in-stent stenoses
and occlusions that occurred in our three patients is only
anecdotal. Nonetheless, it is certainly plausible that these
positional changes are at least partially accountable for
the subsequent complications. Future review of concur-
rent computed tomography and magnetic resonance
data will provide additional data to evaluate stent and
stent-graft position and configuration changes. Addi-
tionally, it emphasizes the potential range of effects that a
stent design can have on its clinical success. With the rapid
influx of new medical devices into the vascular arena, it is
important to remain ever mindful of the profound effect
that subtle differences in design can have on clinical out-
comes.
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